🔗 Permalink

Inventor profile of:

Elijah M. Bolotin

City:

Bothell, Washington

Country:

United States

Published Applications:

Last publication date:

2026-01-15

Top Assignees for applications by Elijah M. Bolotin

The entities that hold a legal rights for patent applications filed by inventor Bolotin Elijah M.:

PharmaIN Corporation 10 Seattle, WA United States
PharmaIN Corporation 9 Bothell, WA United States
Pharmaln Corporation 3 Bothell, WA United States
Pharmal N Corporation 1 Seattle, WA United States
Pharmaln Ltd. 1 Seattle, WA United States
PharmalN Corporation 1 Seattle, WA United States

Recent patent applications by Bolotin Elijah M.

Elijah M. Bolotin from Bothell, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-15

US20260015389A1

Chemistry; metallurgy

V1A Receptor Partial Agonist and Method of Use

#2 | 2024-10-03

US20240325544A1

Human necessities

CATIONIC LIPID FOR COVALENT MODIFICATION OF PEPTIDES

#3 | 2020-08-13

US20200254100A1

Human necessities

ANIONIC-CORE COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USING THE SAME

#4 | 2020-01-16

US20200017567A1

Chemistry; metallurgy

NPRA AGONISTS, COMPOSITIONS, AND USES THEREOF

#5 | 2018-10-04

US20180280516A1

Human necessities

Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same

#6 | 2017-12-28

US20170368190A1

Human necessities

Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

#7 | 2014-06-05

US20140154203A1

Human necessities

Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

#8 | 2014-02-20

US20140051628A1

Chemistry; metallurgy

Composition for long-acting peptide analogs

#9 | 2012-07-26

US20120190097A1

Human necessities

Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same

#10 | 2011-08-25

US20110207662A1

Chemistry; metallurgy

Composition for long-acting peptide analogs

#11 | 2011-02-24

US20110044968A1

Human necessities

COMPOSITIONS FOR TREATMENT WITH METALLOPEPTIDASES, METHODS OF MAKING AND USING THE SAME

#12 | 2010-09-16

US20100234279A1

Chemistry; metallurgy

Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

#13 | 2010-09-02

US20100221184A1

Human necessities

Compositions for delivery of therapeutics and other materials

#14 | 2010-06-24

US20100158806A1

Human necessities

Compositions for delivery of therapeutics and other materials

#15 | 2010-04-22

US20100098636A1

Human necessities

Compositions for delivery of therapeutics and other materials

#16 | 2010-03-18

US20100069293A1

Human necessities

POLYMERIC CARRIER COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS, METHODS OF MAKING AND USING THE SAME

#17 | 2009-07-09

US20090176892A1

Chemistry; metallurgy

Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same

#18 | 2009-06-18

US20090156459A1

Chemistry; metallurgy

Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same

#19 | 2009-04-02

US20090088387A1

Chemistry; metallurgy

Composition for long-acting peptide analogs

#20 | 2009-02-26

US20090053169A1

Human necessities

Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same

#21 | 2008-01-17

US20080015263A1

Human necessities

Compositions for delivery of therapeutics and other materials

#22 | 2007-06-21

US20070141145A1

Human necessities

HYDROPHOBIC CORE CARRIER COMPOSITIONS FOR DELIVERY OF THERAPEUTIC AGENTS, METHODS OF MAKING AND USING THE SAME

InventorID:

659022 ⎘